• Blog
  • Fibrinogen Concentrate Market Growth Analysis | 2022-2028

    Fibrinogen Concentrate Market Growth Analysis | 2022-2028

    Fibrinogen Concentrate Market Growth Analysis | 2022-2028
    Report code - SR1169 Delivery - 2 Weeks
    Fibrinogen Concentrate Market Size, Share, Trends, Dynamics, Forecast, & Growth A See more...

    Market Insights

    The fibrinogen concentrate market size was estimated at USD 2.79 billion in 2021 and is likely to grow at a CAGR of 5.53% during 2022-2028 to reach USD 4.09 billion by 2028.

    Fibrinogen-Concentrate-Market-Insights

    Wish to get a free sample? Click Here.

    What is Fibrinogen concentrate?

    Fibrinogen concentrate is defined as a blood coagulation factor used in the treatment of acute bleeding episodes in patients who have congenital fibrinogen deficiency including afibrinogenemia and hypofibrinogenemia. Fibrinogen concentrate can be categorized as human fibrinogen concentrates and animal fibrinogen concentrates.

    COVID-19 Impact

    The Covid-19 outbreak posed significant challenges on the healthcare sector across geographies. It impacted the progress of the market negatively as only essential and emergency healthcare services were being provided in the hospitals and thus, affected the market progress for a short period of time.

    Fibrinogen Concentrate Market Report Overview

    Market Size in 2028

    USD 4.09 Billion

    Market Size in 2021

    USD 2.79 Billion

    Market Growth (2022-2028)

    CAGR of 5.53%

    Base Year of Study

    2021

    Trend Period

    2016-2020

    Forecast Period

    2022-2028

    Key Players

    The key players operating in the market are-

    • Green Cross Corporation (South Korea),
    • Octapharma AG (Switzerland),
    • The LFB group (France),
    • Thermo Fisher Scientific (The U.S),
    • The Merck Group (Germany),
    • Affinity Biologicals Inc (Canada),
    • Cayman Chemical Company (The U.S),
    • Molecular Innovations (The U.S),
    • CSL Limited (Australia),
    • AkronBiotech (The U.S),
    • Enzo Life Sciences, Inc. (The U.S) and
    • Bovogen Biologicals Pty Ltd. (Australia).

    Market Dynamics

    The growth of the market is primarily driven by:

    • Rising incidences of blood related disorders due to stress and changing lifestyle.
    • Increasing use of fibrinogen concentrate to treat congenital deficiencies is likely to propel the global fibrinogen concentrate market progress at a significant rate during the review period.
    • In addition to this, increasing investment in research and development activities is likely to create lucrative opportunities for the players operating in the global market in the coming years.

    Latest Trends

    The fibrinogen concentrate market is expected to experience significant growth due to the increasing prevalence of hemophilia and advancements in fibrinogen-related products. With more than 350,000 hemophilia cases and more than 70% of affected individuals not receiving proper treatment, the market is expected to grow. A 2019 review by the Journal of Apoplexy and Haemostasis, Fibclot and Clottafact found that human fibrinogen concentrate is effective in treating patients with fibrinogen deficiency. The increasing prevalence of hemophilia and the safety and efficacy of human fibrinogen concentrate are expected to drive market development in this area.

    Restraining Factors

    Fibrinogen concentrate can cause side effects like chills, fever, sickness, and heaving, which can be severe. Adverse effects include anaphylactic reactions, which can be a sensitivity side effect or first signs of touchiness. If these reactions occur, it is crucial to stop using the drug immediately. In patients with inborn fibrinogen deficiency, apoplexy can occur both with and without fibrinogen substitution treatment. Patients receiving fibrinogen concentrate may also experience pneumonic embolism, myocardial localized necrosis, deep vein apoplexy, and blood vessel apoplexy signs and side effects.

    Fibrinogen-Concentrate-Market-Dynamics

    Want to have a closer look at this report? Get a Free Sample.

    Segments Analysis

    Segmentations

    List of Sub-Segments

    Dominant and Fastest-Growing Segments

    Type Analysis

    Human Fibrinogen Concentrates, Animal Fibrinogen Concentrates

    The forecasted period's largest segment share is expected to be human fibrinogen concentrate.

    Application Analysis

    Hospitals, Ambulatory Surgical Centers, Others

    The hospitals segment accounted for the largest market share in 2021 and is projected to register significant growth during the forecast period.

    Regional Analysis

    North America, Europe, Asia-Pacific, Middle East and Africa, and South America

    North America accounted for the largest market share in 2021 and is projected to grow at a significant CAGR during the assessment period.

    Type

    The market has been bifurcated into human fibrinogen concentrates, animal fibrinogen concentrates. The forecasted period's largest segment share is expected to be human fibrinogen concentrate, driven by the growing demand for fibrinogen concentrate for treating bleeding disorders and congenital coagulation deficiencies.

    Application Type

    The market has been bifurcated into hospitals, ambulatory surgical centers and others. Under these, the hospitals segment accounted for the largest market share in 2021 and is projected to register significant growth during the review period on account of presence of established healthcare infrastructure and professional healthcare staff.

    Regional Analysis

    The market in North America accounted for the largest market share in 2021 and is projected to grow at a significant CAGR during the assessment period. The regional growth can be attributed to increasing incidences of blood related disorders and presence of key market players such as Thermo Fisher Scientific (The U.S) and Cayman Chemical Company (The U.S). The market progress in Asia-Pacific region is expected to be driven by increasing use of fibrinogen concentrate in treating congenital deficiencies.

    Fibrinogen-Concentrate-Market-Regional-Analysis

    To know high-growth countries in this report, Register Here.

    Critical Questions Answered in the Report

    • What are the key trends in the market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the market?
    • What are the key strategies adopted by the major vendors to lead in the market?
    • What is the market share of the top vendors?

    Market Segmentation

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the global fibrinogen concentrate market.

    The fibrinogen concentrate market is segmented into the following categories:

    By type:

    • Human Fibrinogen Concentrates
    • Animal Fibrinogen Concentrates

    By application type:

    • Hospitals
    • Ambulatory Surgical Centers
    • Others

    By region:

    • North America (Country Analysis: the USA, Canada, and Mexico)
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and the Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and the Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Fibrinogen-Concentrate-Market-Segmentation

    Click Here, to learn the market segmentation details.

    Target Audience

    Here is the list of the group of customers that the fibrinogen concentrate market hopes to have the greatest opportunity to convert-

    • Distributors
    • Suppliers
    • Manufacturers
    • Logistics organizations
    • Government bodies

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the dynamics and will enable strategic decision-making for the existing players as well as those willing to enter the fibrinogen concentrate market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth analysis of the Fibrinogen Concentrate Market

    How lucrative is the future?

    The market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape and Market share analysis

    How complex is the business environment?

    Porter’s five forces, PEST and Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Customization Options

    Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players).
    • SWOT analysis of key players (up to 3 players).

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Fibrinogen concentrate is defined as a blood coagulation factor used in the treatment of acute bleeding episodes in patients who have congenital fibrinogen deficiency including afibrinogenemia and hypofibrinogenemia. Fibrinogen concentrate can be categorized as human fibrinogen concentrates and animal fibrinogen concentrates.

    The fibrinogen concentrate market is expected to grow at a CAGR of 5.53 % during the upcoming five years.

    Increasing use of fibrinogen concentrate to treat congenital deficiencies is likely to propel the market progress at a significant rate during the review period. In addition to this, increasing investment in research and development activities is likely to create lucrative opportunities for the players operating in the global market in the coming years.

    The fibrinogen concentrate market size is estimated to grow from USD 2.79 Bn in 2021 to USD 4.09 Bn by 2028.

    North America is expected to largest share of the market during the assessment period.

    The LFB group (France), Green Cross Corporation (South Korea), Octapharma AG (Switzerland), Thermo Fisher Scientific (The U.S), The Merck Group (Germany), Affinity Biologicals Inc (Canada), Cayman Chemical Company (The U.S), Molecular Innovations (The U.S), CSL Limited (Australia), AkronBiotech (The U.S), Enzo Life Sciences, Inc. (The U.S) and Bovogen Biologicals Pty Ltd. (Australia). are the key companies in the market.

    The hospitals segment has the largest share of the market during the estimated time.

    The study period of the market is 2016-2028.